145 related articles for article (PubMed ID: 9669318)
1. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis.
Yang AJ; Chandswangbhuvana D; Margol L; Glabe CG
J Neurosci Res; 1998 Jun; 52(6):691-8. PubMed ID: 9669318
[TBL] [Abstract][Full Text] [Related]
2. Astrocytic uptake of posttranslationally modified amyloid-β leads to endolysosomal system disruption and induction of pro-inflammatory signaling.
Wirth S; Schlößer A; Beiersdorfer A; Schweizer M; Woo MS; Friese MA; Lohr C; Grochowska KM
Glia; 2024 Aug; 72(8):1451-1468. PubMed ID: 38629411
[TBL] [Abstract][Full Text] [Related]
3. Misfolded amyloid-β-42 impairs the endosomal-lysosomal pathway.
Marshall KE; Vadukul DM; Staras K; Serpell LC
Cell Mol Life Sci; 2020 Dec; 77(23):5031-5043. PubMed ID: 32025743
[TBL] [Abstract][Full Text] [Related]
4. Membrane localization of beta-amyloid 1-42 in lysosomes: a possible mechanism for lysosome labilization.
Liu RQ; Zhou QH; Ji SR; Zhou Q; Feng D; Wu Y; Sui SF
J Biol Chem; 2010 Jun; 285(26):19986-96. PubMed ID: 20430896
[TBL] [Abstract][Full Text] [Related]
5. Tau fibrils induce nanoscale membrane damage and nucleate cytosolic tau at lysosomes.
Rose K; Jepson T; Shukla S; Maya-Romero A; Kampmann M; Xu K; Hurley JH
Proc Natl Acad Sci U S A; 2024 May; 121(22):e2315690121. PubMed ID: 38781206
[TBL] [Abstract][Full Text] [Related]
6. Loss of neuronal lysosomal acid lipase drives amyloid pathology in Alzheimer's disease.
Barnett AM; Dawkins L; Zou J; McNair E; Nikolova VD; Moy SS; Sutherland GT; Stevens J; Colie M; Katemboh K; Kellner H; Damian C; DeCastro S; Vetreno RP; Coleman LG
bioRxiv; 2024 Jun; ():. PubMed ID: 38915509
[TBL] [Abstract][Full Text] [Related]
7. Tau fibrils induce nanoscale membrane damage and nucleate cytosolic tau at lysosomes.
Rose K; Jepson T; Shukla S; Maya-Romero A; Kampmann M; Xu K; Hurley JH
bioRxiv; 2023 Aug; ():. PubMed ID: 37693477
[TBL] [Abstract][Full Text] [Related]
8. Tau-targeting therapies for Alzheimer disease: current status and future directions.
Congdon EE; Ji C; Tetlow AM; Jiang Y; Sigurdsson EM
Nat Rev Neurol; 2023 Dec; 19(12):715-736. PubMed ID: 37875627
[TBL] [Abstract][Full Text] [Related]
9. Treatment with cholesterol just after thawing maintains the fertility of bull sperm.
Islam MM; Umehara T; Tsujita N; Koyago M; Shimada M
Mol Hum Reprod; 2023 Aug; 29(9):. PubMed ID: 37656939
[TBL] [Abstract][Full Text] [Related]
10. Towards the Integrative Theory of Alzheimer's Disease: Linking Molecular Mechanisms of Neurotoxicity, Beta-amyloid Biomarkers, and the Diagnosis.
Molkov YI; Zaretskaia MV; Zaretsky DV
Curr Alzheimer Res; 2023; 20(6):440-452. PubMed ID: 37605411
[TBL] [Abstract][Full Text] [Related]
11. Endolysosomal impairment by binding of amyloid beta or MAPT/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease.
Kim SH; Cho YS; Kim Y; Park J; Yoo SM; Gwak J; Kim Y; Gwon Y; Kam TI; Jung YK
Autophagy; 2023 Aug; 19(8):2318-2337. PubMed ID: 36843263
[TBL] [Abstract][Full Text] [Related]
12. Insights of Endocytosis Signaling in Health and Disease.
Pathak C; Vaidya FU; Waghela BN; Jaiswara PK; Gupta VK; Kumar A; Rajendran BK; Ranjan K
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769293
[TBL] [Abstract][Full Text] [Related]
13. Patients with Alzheimer's disease have an increased removal rate of soluble beta-amyloid-42.
Zaretsky DV; Zaretskaia MV; Molkov YI;
PLoS One; 2022; 17(10):e0276933. PubMed ID: 36315527
[TBL] [Abstract][Full Text] [Related]
14. Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions.
Magalhães JD; Fão L; Vilaça R; Cardoso SM; Rego AC
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829854
[TBL] [Abstract][Full Text] [Related]
15. Selective Neutral pH Inhibitor of Cathepsin B Designed Based on Cleavage Preferences at Cytosolic and Lysosomal pH Conditions.
Yoon MC; Solania A; Jiang Z; Christy MP; Podvin S; Mosier C; Lietz CB; Ito G; Gerwick WH; Wolan DW; Hook G; O'Donoghue AJ; Hook V
ACS Chem Biol; 2021 Sep; 16(9):1628-1643. PubMed ID: 34416110
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease BIN1 coding variants increase intracellular Aβ levels by interfering with BACE1 recycling.
Perdigão C; Barata MA; Burrinha T; Guimas Almeida C
J Biol Chem; 2021 Sep; 297(3):101056. PubMed ID: 34375641
[TBL] [Abstract][Full Text] [Related]
17. Endo-lysosomal Aβ concentration and pH trigger formation of Aβ oligomers that potently induce Tau missorting.
Schützmann MP; Hasecke F; Bachmann S; Zielinski M; Hänsch S; Schröder GF; Zempel H; Hoyer W
Nat Commun; 2021 Jul; 12(1):4634. PubMed ID: 34330900
[TBL] [Abstract][Full Text] [Related]
18. Detection of retinal and blood Aβ oligomers with nanobodies.
Habiba U; Descallar J; Kreilaus F; Adhikari UK; Kumar S; Morley JW; Bui BV; Koronyo-Hamaoui M; Tayebi M
Alzheimers Dement (Amst); 2021; 13(1):e12193. PubMed ID: 33977118
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin D: A Candidate Link between Amyloid β-protein and Tauopathy in Alzheimer Disease.
Suire CN; Leissring MA
J Exp Neurol; 2021; 2(1):10-15. PubMed ID: 33665647
[TBL] [Abstract][Full Text] [Related]
20. Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies.
Silva MC; Haggarty SJ
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
